-
and apply them in clinical studies across different disease areas to generate novel biological insights. As part of the network-wide training programme, you will collaborate with leading international
-
The Neuropathology Research team is part of the department of Pathology at Amsterdam UMC. The team consists of neuroscientists and neuropathologists working on research into neurodegenerative
-
organisation is the University of York, UK. The selected candidate will be employed by the University of York and become part of the POLARIS consortium, with academic supervision and disease-specific expertise
-
FDA-approved drug library repurposing and fragment-based drug discovery (FBDD) to search for potential modulators. As part of the POLARIS doctoral network, you will develop a functional GPCR assay
-
you to bring together different scientific perspectives and contribute to knowledge that can support the development and accessibility of therapies for rare diseases. As part of the POLARIS network, you
-
at Amsterdam UMC and POLARIS partner organisations and participating in network-wide training activities and planned secondments. You will be part of an international and interdisciplinary research environment
-
biological reference point for identifying disease-specific biomarkers. A central part of the project is the use of iPSC-derived models, including oligodendrocytes, astrocytes, neurons and myelinating
-
and apply them in clinical studies across different disease areas to generate novel biological insights. As part of the network-wide training programme, you will collaborate with leading international
-
symptoms develop. Ultimately, the consortium seeks to enable timely lifestyle interventions that help prevent chronic disease rather than treat it. As a PhD candidate, you will become part of a
-
machine-learning approaches. Established markers such as neurofilament light chain (NfL) and GFAP will provide a biological reference point for identifying disease-specific biomarkers. A central part of the